Press release | 17th February 2010
IDBS Announces E-WorkBook Suite 8.2
Confirms E-WorkBook as Leading ELN for Research and Preclinical Drug Development
Guildford, UK, and Burlington, Mass., February 17, 2010 – IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced the availability of E-WorkBook Suite 8.2, the newest release of its next-generation electronic lab notebook (ELN).
E-WorkBook Suite provides a versatile electronic lab notebook that captures and stores both contextual and experimental fact data in a searchable, secure, traceable and compliant environment. The new version, available today, provides enhanced support for controlled data entry processes, easier and faster data entry and analysis, and Intellectual Property (IP) protection capabilities.
“We are seeing a unique and important shift in the pharma and biotech industries where companies are moving from a document-centric view of the enterprise to a data-centric view – a transition that requires R&D to streamline and adapt quickly to changing business processes,” said Ruchi Mallya, Pharmaceutical Technology Analyst at Ovum. “Solutions such as E-WorkBook are making this task easier for researchers by changing the way data is captured, analyzed and reported, giving them flexibility in how they run their scientific experiments and reducing their time to access data.”
Reducing the Burden of Regulatory Compliance
E-WorkBook is used in many regulated DMPK, Bioanalysis, Formulations, and Toxicology laboratories that require rigorous control of workflows and data entry processes. This latest version includes enhanced template intelligence features, including non-deletable items, enforced sequential data entry, granular drag-and-drop and full template version tracking, all of which reduce the cost and complexity of regulatory compliance. For example, the ability to search and find experiments that used a specific template name and version significantly improves traceability and problem resolution.
Increased Security and Speed
E-WorkBook now includes plug-and-play integration with digital signature infrastructures that enables researchers to even more easily protect their IP and conform to company policies. Version 8.2 is certified by SAFE-BioPharma, the pharmaceutical industry’s signature standards body. Any SAFE-BioPharma compliant electronic identity system can be quickly and easily configured to work with E-WorkBook. Version 8.2 also includes performance improvements to curve fitting functions, pdf generation, data loading, search capabilities and chemistry queries.
Customer Requested Enhancements
This release includes significant enhancements to multistep chemical pathway generation, rendering and searching, which are of particular importance in Metabolite Identification and Process Optimization. A ‘Print To’ function, increased data exchange capabilities and enhanced analytical data capture and visualization are all features that scientists in the areas of method development and validation describe as class-leading.
“E-WorkBook continues to set the standard for ELNs and with this new version we once again raise the bar for functionality, speed and flexibility,” said Glyn Williams, VP of Product Delivery at IDBS. “E-WorkBook has been deployed in R&D organizations across many industries and every day enables thousands of users to see more productive research and realize results faster. IDBS is committed to continually investing in its world-class products to meet the evolving needs of our customers as they strive to accelerate and streamline their research efforts.”
IDBS is a unique, global supplier of innovative data management and analytics solutions, which increase efficiency, reduce costs and improve business and scientific productivity of R&D organizations worldwide. Organizations such as Pfizer, GSK, Celera, MedImmune, Dana-Farber, and Roche employ IDBS solutions as an integral part of their strategy to address the increasing pressures placed upon them by the need for the secure, compliant capture, integration and analysis of complex research data. IDBS is clearly differentiated from other software providers by its unique combination of deep domain knowledge and its ability to rapidly provide integrated business process and robust data analytics solutions along the entire R&D value chain. IDBS solutions secure organizations’ valuable R&D data assets and enable rapid decision-making through effective integration and analysis. They also support the protection of Intellectual Property (IP) and the requirements for data quality demanded under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.
IDBS is a private company, founded in 1989 and headquartered in Guildford, UK. IDBS has worldwide consulting and support presence, with U.S. offices in California, New Jersey and Massachusetts, the EU, Australia and China.